基于价值的睡眠与呼吸：阻塞性睡眠呼吸暂停的健康经济学方面
Value-based sleep and breathing: health economic aspects of obstructive sleep apnea.
作者信息
Wickwire Emerson M
机构信息
Sleep Disorders Center, Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA; Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA.
出版信息
Fac Rev. 2021 Apr 19;10:40. doi: 10.12703/r/10-40. eCollection 2021.
Abstract
Obstructive sleep apnea (OSA) is a common and costly medical condition. Untreated OSA is associated with numerous and well-documented adverse health consequences including depression, diabetes, cardiovascular disease, and premature death. In addition to these health consequences, untreated OSA is also associated with substantial costs borne by patients, payers, the health system, and society at large. Perhaps more importantly, evidence suggests that OSA treatment is associated with positive economic benefit. The purpose of this brief review is to introduce economic aspects of OSA, including the potential economic benefit of OSA treatment.
摘要
阻塞性睡眠呼吸暂停（OSA）是一种常见且代价高昂的医学病症。未经治疗的OSA与众多且有充分文献记载的不良健康后果相关，包括抑郁症、糖尿病、心血管疾病和过早死亡。除了这些健康后果外，未经治疗的OSA还会给患者、支付方、卫生系统以及整个社会带来巨大成本。或许更重要的是，有证据表明OSA治疗具有积极的经济效益。本简要综述的目的是介绍OSA的经济方面，包括OSA治疗的潜在经济效益。
相似文献
1
Value-based sleep and breathing: health economic aspects of obstructive sleep apnea.基于价值的睡眠与呼吸：阻塞性睡眠呼吸暂停的健康经济学方面
Fac Rev. 2021 Apr 19;10:40. doi: 10.12703/r/10-40. eCollection 2021.
2
Obstructive sleep apnea: personal, societal, public health, and legal implications.阻塞性睡眠呼吸暂停：个人、社会、公共卫生和法律影响。
Rev Environ Health. 2019 Jun 26;34(2):153-169. doi: 10.1515/reveh-2018-0068.
3
The invisible costs of obstructive sleep apnea (OSA): Systematic review and cost-of-illness analysis.阻塞性睡眠呼吸暂停（OSA）的无形代价：系统评价和疾病成本分析。
PLoS One. 2022 May 20;17(5):e0268677. doi: 10.1371/journal.pone.0268677. eCollection 2022.
4
Obstructive sleep apnea: diagnosis, epidemiology, and economics.阻塞性睡眠呼吸暂停：诊断、流行病学和经济学。
Respir Care. 2010 Sep;55(9):1155-67.
5
Cost-effectiveness of obstructive sleep apnea screening for patients with diabetes or chronic kidney disease.阻塞性睡眠呼吸暂停筛查对糖尿病或慢性肾脏病患者的成本效益分析
Sleep Breath. 2015 Sep;19(3):1081-92. doi: 10.1007/s11325-015-1134-x. Epub 2015 Feb 3.
6
Obstructive sleep apnea.阻塞性睡眠呼吸暂停
Dis Mon. 1994 Apr;40(4):197-252. doi: 10.1016/0011-5029(94)90013-2.
7
Obstructive sleep apnea: implications for cardiac and vascular disease.阻塞性睡眠呼吸暂停：对心脏和血管疾病的影响。
JAMA. 2003 Oct 8;290(14):1906-14. doi: 10.1001/jama.290.14.1906.
8
Sleep-Disordered Breathing.睡眠呼吸障碍
Continuum (Minneap Minn). 2017 Aug;23(4, Sleep Neurology):1093-1116. doi: 10.1212/01.CON.0000522245.13784.f6.
9
Cost-effectiveness of continuous positive airway pressure therapy for obstructive sleep apnea: health care system and societal perspectives.持续气道正压通气治疗阻塞性睡眠呼吸暂停的成本效益：卫生保健系统和社会视角。
Sleep. 2019 Dec 24;42(12). doi: 10.1093/sleep/zsz181.
10
The Association between Treated and Untreated Obstructive Sleep Apnea and Depression.经治疗与未经治疗的阻塞性睡眠呼吸暂停与抑郁症之间的关联
Neurodiagn J. 2018;58(1):30-39. doi: 10.1080/21646821.2018.1428462.
引用本文的文献
1
Validating a smart bed against polysomnography for sleep apnea detection.验证一款智能床用于睡眠呼吸暂停检测的效果，与多导睡眠图进行对比。
Sci Rep. 2025 Jul 2;15(1):23607. doi: 10.1038/s41598-025-07336-4.
2
Detection of sleep apnea using smartphone-embedded inertial measurement unit.使用嵌入智能手机的惯性测量单元检测睡眠呼吸暂停。
Sci Rep. 2025 Apr 28;15(1):14923. doi: 10.1038/s41598-025-99801-3.
3
An Explainable Fusion of ECG and SpO-Based Models for Real-Time Sleep Apnea Detection.一种用于实时睡眠呼吸暂停检测的基于心电图（ECG）和血氧饱和度（SpO）模型的可解释融合方法。
Bioengineering (Basel). 2025 Apr 3;12(4):382. doi: 10.3390/bioengineering12040382.
4
Novel assessment of CPAP adherence data reveals distinct diurnal patterns.持续气道正压通气依从性数据的新评估揭示了不同的昼夜模式。
J Clin Sleep Med. 2025 Mar 1;21(3):493-502. doi: 10.5664/jcsm.11446.
5
An Objective Study to Establish Incidence of True Obstructive Sleep Apnoea (OSA) in Sleep Disordered Breathing in the Paediatric Age Group and Assessment of Benefit of Surgery (Tonsillectomy and Adenoidectomy) in Non Responders to Medical Treatment in Mild OSA.一项关于确定小儿年龄组睡眠呼吸障碍中真性阻塞性睡眠呼吸暂停（OSA）发病率以及评估轻度OSA中对药物治疗无反应者手术（扁桃体切除术和腺样体切除术）获益情况的客观研究。
Indian J Otolaryngol Head Neck Surg. 2024 Oct;76(5):4189-4199. doi: 10.1007/s12070-024-04813-6. Epub 2024 Jun 25.
6
A Deep Learning Method for Human Sleeping Pose Estimation with Millimeter Wave Radar.基于毫米波雷达的人体睡眠姿势估计的深度学习方法。
Sensors (Basel). 2024 Sep 11;24(18):5900. doi: 10.3390/s24185900.
7
Evaluation of an OSA Risk Screening Smartphone App in a General, Non-Symptomatic Population Sample (ESOSA).在一般无症状人群样本中对一款阻塞性睡眠呼吸暂停风险筛查智能手机应用程序（ESOSA）的评估。
J Clin Med. 2024 Aug 8;13(16):4664. doi: 10.3390/jcm13164664.
8
Obstructive sleep apnea remains a risk factor for major adverse cardiovascular and cerebrovascular events even in hypertensive patients under treatment: the Urumqi Research on Sleep Apnea and Hypertension (UROSAH) data.即使在接受治疗的高血压患者中，阻塞性睡眠呼吸暂停仍是主要不良心血管和脑血管事件的危险因素：乌鲁木齐睡眠呼吸暂停与高血压研究（UROSAH）数据。
Cardiovasc Diagn Ther. 2023 Dec 15;13(6):968-978. doi: 10.21037/cdt-23-284. Epub 2023 Dec 5.
9
Prevalence of Sleep Disturbances in Latin American Populations and Its Association with Their Socioeconomic Status-A Systematic Review and a Meta-Analysis.拉丁美洲人群睡眠障碍的患病率及其与社会经济地位的关联——一项系统评价和荟萃分析
J Clin Med. 2023 Dec 5;12(24):7508. doi: 10.3390/jcm12247508.
10
The OSA patient journey: pathways for diagnosis and treatment among commercially insured individuals in the United States.阻塞性睡眠呼吸暂停患者的就医之旅：美国商业保险个体的诊断和治疗途径。
J Clin Sleep Med. 2024 Apr 1;20(4):505-514. doi: 10.5664/jcsm.10908.
本文引用的文献
1
Lower socioeconomic status and co-morbid conditions are associated with reduced continuous positive airway pressure adherence among older adult medicare beneficiaries with obstructive sleep apnea.较低的社会经济地位和合并症与老年医疗保险受益人群阻塞性睡眠呼吸暂停患者持续气道正压通气治疗依从性降低有关。
Sleep. 2020 Dec 14;43(12). doi: 10.1093/sleep/zsaa122.
2
A workshop report on the causes and consequences of sleep health disparities.睡眠健康差距的原因和后果研讨会报告
Sleep. 2020 Aug 12;43(8). doi: 10.1093/sleep/zsaa037.
3
Clinical- and Cost-Effectiveness of a Mandibular Advancement Device Versus Continuous Positive Airway Pressure in Moderate Obstructive Sleep Apnea.下颌前移装置与持续气道正压通气治疗中重度阻塞性睡眠呼吸暂停的临床和成本效益比较。
J Clin Sleep Med. 2019 Oct 15;15(10):1477-1485. doi: 10.5664/jcsm.7980.
4
Association of Positive Airway Pressure Use With Acute Care Utilization and Costs.正压通气使用与急性护理利用和成本的关系。
J Clin Sleep Med. 2019 Sep 15;15(9):1243-1250. doi: 10.5664/jcsm.7912.
5
Association between adherence to continuous positive airway pressure treatment and cost among medicare enrollees.医疗保险参保者遵医嘱使用持续气道正压通气治疗与成本的相关性。
Sleep. 2020 Jan 13;43(1). doi: 10.1093/sleep/zsz188.
6
Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis.基于文献的分析估计全球阻塞性睡眠呼吸暂停的患病率和负担。
Lancet Respir Med. 2019 Aug;7(8):687-698. doi: 10.1016/S2213-2600(19)30198-5. Epub 2019 Jul 9.
7
The Impact of Treatments for OSA on Monetized Health Economic Outcomes: A Systematic Review.OSA 治疗对货币化健康经济结果的影响：系统评价。
Chest. 2019 May;155(5):947-961. doi: 10.1016/j.chest.2019.01.009. Epub 2019 Jan 18.
8
Trends of cost-effectiveness studies in sleep medicine.睡眠医学中成本效益研究的趋势。
Sleep Med. 2019 Jan;53:176-180. doi: 10.1016/j.sleep.2018.06.001. Epub 2018 Jun 18.
9
Value and Payment in Sleep Medicine.睡眠医学中的价值与支付
J Clin Sleep Med. 2018 May 15;14(5):881-884. doi: 10.5664/jcsm.7130.
10
Adherence to positive airway pressure treatment among minority populations in the US: A scoping review.美国少数族裔人群对气道正压治疗的依从性：范围综述。
Sleep Med Rev. 2018 Apr;38:56-69. doi: 10.1016/j.smrv.2017.04.002. Epub 2017 Apr 13.
Zotero 插件